Structured evidence table for Hesperidin Blood Pressure Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Hesperidin Blood Pressure Meta-Analysis | However, in sharp contrast, the heart rate reduced significantly after intake of MPFF (88.8 ± 10.5 bpm vs. | 4 | Rodrigues JAL (2025) | Case Report: Micronized purified flavonoid fraction [Daflon]-induced bradycardia. |
| Hesperidin Blood Pressure Meta-Analysis | 79.3 ± 9.7 bpm; p Conclusion We reported a new effect of MPFF as an attenuator of the heart rate. | 4 | Rodrigues JAL (2025) | Case Report: Micronized purified flavonoid fraction [Daflon]-induced bradycardia. |
| Hesperidin Blood Pressure Meta-Analysis | Introduction Flavonoids are oral venoactive drugs frequently prescribed to relieve the symptoms of chronic venous disorders. | 4 | Rodrigues JAL (2025) | Case Report: Micronized purified flavonoid fraction [Daflon]-induced bradycardia. |
| Hesperidin Blood Pressure Meta-Analysis | Micronized purified flavonoid fraction (MPFF, commercial Daflon 1000 mg) is a preparation that contains mainly diosmin and a small fraction of hesperidin. | 4 | Rodrigues JAL (2025) | Case Report: Micronized purified flavonoid fraction [Daflon]-induced bradycardia. |
| Hesperidin Blood Pressure Meta-Analysis | Systemic hypertension is a major global health concern, significantly contributing to the risk of cardiovascular, cerebrovascular, and renal diseases. | 4 | Orengo SLD (2025) | Prolonged Diuretic, Natriuretic, and Potassium- and Calcium-Sparing Effect of Hesperidin in Hypertensive Rats. |
| Hesperidin Blood Pressure Meta-Analysis | Antihypertensive medications play a crucial role in lowering blood pressure, with diuretics serving as a particularly effective first-line therapy. | 4 | Orengo SLD (2025) | Prolonged Diuretic, Natriuretic, and Potassium- and Calcium-Sparing Effect of Hesperidin in Hypertensive Rats. |
Source documents